Saturday, November 7, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Decoy Peptides Target PIWIL2 Gene Fusion to Combat Hepatocellular Carcinoma

Researchers have identified an oncogenic SLC39A14-PIWIL2 fusion gene in hepatocellular carcinoma and engineered synthetic decoy peptides that disrupt downstream protein…

PR
By Priya Raman · Science Reporter
Nov 7 06:53 ETSource: Bioengineer.org

From the source

Decoy Peptides Target PIWIL2 Gene Fusion to Combat Hepatocellular Carcinoma

Researchers have identified an oncogenic SLC39A14-PIWIL2 fusion gene in hepatocellular carcinoma and engineered synthetic decoy peptides that disrupt downstream protein interactions to suppress tumor growth and reverse chemoresistance.

Read at bioengineer.org
PeptiPrescribed peptides from $99/moSee all →